Home › Carcinoma a cellule squamose della testa e del collo › Texas › San Antonio
Studi clinici su Carcinoma a cellule squamose della testa e del collo a San Antonio, TX
22 studi su Carcinoma a cellule squamose della testa e del collo cercano partecipanti presso sedi a San Antonio e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
In reclutamentoFase 1
- South Texas Accelerated Research Therapeutics (START), San Antonio
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
In reclutamentoFase 1
- NEXT Oncology, San Antonio
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
In reclutamentoFase 1
- NEXT Oncology - PARENT, San Antonio
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
In reclutamentoFase 1/2
- START South Texas Accelerated Research Therapeutics, San Antonio
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
In reclutamentoFase 1/2
- START Center for Cancer Research, San Antonio
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
In reclutamentoStudio osservazionale
- The University of Texas Health Science Center at San Antonio, San Antonio
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
In reclutamentoFase 1/2
- NEXT Oncology - San Antonio, San Antonio
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
In reclutamentoFase 1
- Site 102 - START San Antonio, San Antonio
ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
In reclutamentoFase 1
- START San Antonio, San Antonio
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
In reclutamentoFase 1
- START-San Antonio, San Antonio
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- Research Site, San Antonio
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
In reclutamentoFase 1
- Normunity Investigational Site, San Antonio
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
In reclutamentoFase 1/2
- START San Antonio, San Antonio
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
In reclutamentoFase 1
- NEXT Virginia, LLC, San Antonio
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
In reclutamentoFase 1/2
- START San Antonio, San Antonio
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
In reclutamentoFase 1/2
- START, San Antonio
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
In reclutamentoFase 1
- NEXT Oncology /ID# 243007, San Antonio
- South Texas Accelerated Research Therapeutics (START) /ID# 276268, San Antonio
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
In reclutamentoFase 1
- NEXT Texas LLC - San Antonio, San Antonio
- START San Antonio, LLC, San Antonio
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
In reclutamentoFase 3
- GSK Investigational Site, San Antonio
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
In reclutamentoFase 1
- NEXT Oncology, San Antonio
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- START San Antonio, San Antonio
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
In reclutamentoFase 1
- Dren Investigational Site, San Antonio
Studi su Carcinoma a cellule squamose della testa e del collo in altre città
- Houston, TX47 studi
- Los Angeles, CA42 studi
- Boston, MA40 studi
- Nashville, TN39 studi
- New York City, NY39 studi
- St. Louis, MO28 studi
- Arlington, VA26 studi
- Chicago, IL26 studi
- Philadelphia, PA26 studi
- Atlanta, GA24 studi
- Pittsburgh, PA22 studi
- New Haven, CT22 studi
Altri studi a San Antonio
- Cancro del polmone non a piccole cellule59 studi
- Cancro al seno47 studi
- Cancro colorettale46 studi
- Cancro metastatico44 studi
- Cancro (tutti i tipi)41 studi
- Obesità40 studi
- Diabete di tipo 237 studi
- Sovrappeso34 studi
- Cancro ovarico31 studi
- Cancro pancreatico31 studi
- Cancro alla prostata28 studi
- Cancro dell'endometrio27 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.